Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
3.435
-0.095 (-2.69%)
At close: Mar 5, 2026, 4:00 PM EST
3.440
+0.005 (0.15%)
Pre-market: Mar 6, 2026, 4:39 AM EST
Outset Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 119.48 | 113.69 | 130.38 | 115.38 | 102.6 | Upgrade
|
| Revenue Growth (YoY) | 5.09% | -12.80% | 13.00% | 12.45% | 105.47% | Upgrade
|
| Cost of Revenue | 72.72 | 74.55 | 101.25 | 97.54 | 94.99 | Upgrade
|
| Gross Profit | 46.75 | 39.14 | 29.13 | 17.83 | 7.61 | Upgrade
|
| Selling, General & Admin | 92.27 | 110.67 | 139.8 | 130 | 101.39 | Upgrade
|
| Research & Development | 21.2 | 36.29 | 56.57 | 48.86 | 36.74 | Upgrade
|
| Operating Expenses | 113.47 | 146.96 | 196.37 | 178.85 | 138.13 | Upgrade
|
| Operating Income | -66.71 | -107.82 | -167.24 | -161.02 | -130.52 | Upgrade
|
| Interest Expense | -13.95 | -23.87 | -12.68 | -3.57 | -1.72 | Upgrade
|
| Interest & Investment Income | 7.41 | 9.76 | 10.17 | 3.29 | 0.5 | Upgrade
|
| EBT Excluding Unusual Items | -73.26 | -121.93 | -169.74 | -161.29 | -131.74 | Upgrade
|
| Merger & Restructuring Charges | 0.01 | -5.56 | -2.53 | - | - | Upgrade
|
| Other Unusual Items | -7.69 | - | - | -1.37 | - | Upgrade
|
| Pretax Income | -80.94 | -127.49 | -172.27 | -162.66 | -131.74 | Upgrade
|
| Income Tax Expense | 0.72 | 0.49 | 0.52 | 0.3 | 0.2 | Upgrade
|
| Earnings From Continuing Operations | -81.65 | -127.98 | -172.8 | -162.96 | -131.94 | Upgrade
|
| Net Income | -81.65 | -127.98 | -172.8 | -162.96 | -131.94 | Upgrade
|
| Net Income to Common | -81.65 | -127.98 | -172.8 | -162.96 | -131.94 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | 339.24% | 4.78% | 2.94% | 5.64% | 178.69% | Upgrade
|
| EPS (Basic) | -5.37 | -36.96 | -52.28 | -50.75 | -43.41 | Upgrade
|
| EPS (Diluted) | -5.37 | -36.96 | -52.28 | -50.75 | -43.41 | Upgrade
|
| Free Cash Flow | -47.13 | -117.22 | -134.81 | -154.05 | -133.37 | Upgrade
|
| Free Cash Flow Per Share | -3.10 | -33.85 | -40.79 | -47.98 | -43.88 | Upgrade
|
| Gross Margin | 39.13% | 34.43% | 22.34% | 15.46% | 7.41% | Upgrade
|
| Operating Margin | -55.84% | -94.84% | -128.27% | -139.56% | -127.21% | Upgrade
|
| Profit Margin | -68.34% | -112.57% | -132.54% | -141.24% | -128.59% | Upgrade
|
| Free Cash Flow Margin | -39.44% | -103.10% | -103.40% | -133.53% | -129.99% | Upgrade
|
| EBITDA | -62.37 | -102.09 | -161.43 | -155.85 | -125.36 | Upgrade
|
| EBITDA Margin | -52.20% | -89.80% | -123.82% | -135.08% | -122.18% | Upgrade
|
| D&A For EBITDA | 4.34 | 5.73 | 5.81 | 5.17 | 5.16 | Upgrade
|
| EBIT | -66.71 | -107.82 | -167.24 | -161.02 | -130.52 | Upgrade
|
| EBIT Margin | -55.84% | -94.84% | -128.27% | -139.56% | -127.21% | Upgrade
|
| Revenue as Reported | 119.48 | 113.69 | 130.38 | 115.38 | 102.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.